Premenstrual Dysphoric Disorder: Epidemiology and Treatment

Liisa Hantsoo, C. Neill Epperson

Research output: Contribution to journalReview articlepeer-review

Abstract

Recently designated as a disorder in the DSM-5, premenstrual dysphoric disorder (PMDD) presents an array of avenues for further research. PMDD’s profile, characterized by cognitive–affective symptoms during the premenstruum, is unique from that of other affective disorders in its symptoms and cyclicity. Neurosteroids may be a key contributor to PMDD’s clinical presentation and etiology, and represent a potential avenue for drug development. This review will present recent literature on potential contributors to PMDD’s pathophysiology, including neurosteroids and stress, and explore potential treatment targets.

Original languageEnglish (US)
Article number87
JournalCurrent psychiatry reports
Volume17
Issue number11
DOIs
StatePublished - Nov 24 2015

Keywords

  • GABA
  • Menstrual cycle
  • PMDD
  • PMS
  • Premenstrual

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Premenstrual Dysphoric Disorder: Epidemiology and Treatment'. Together they form a unique fingerprint.

Cite this